BullBD Old Apps Site
Home
Details Chart Today news Share news Top gainer Top Looser Upcoming events
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0 1 2 3 4 5 6 7 8 9 All
Bank Cement Ceramics Sector Corporate Bond Engineering Financial Institutions Food & Allied Fuel & Power IT Sector Insurance Jute Life Insurance Miscellaneous Mutual Funds Paper & Printing Pharmaceuticals & Chemicals Services & Real Estate Tannery Industries Telecommunication Textile Travel & Leisure All
  • Details
  • Chart
  • News

PHARMAID

All Eps Dividend Board Agm Q1 Q2 Q3

PHARMAID 10-Nov-2021

The Board of Directors has recommended 50% cash dividend for the year ended on June 30, 2021. Date of AGM: 30.12.2021, Time: 11:30 AM, Venue: Digital Platform. Record date: 07.12.2021. The Company has reported EPS of Tk. 16.11, NAV per share of Tk. 93.26 and NOCFPS of Tk. 10.07 for the year ended on June 30, 2021 as against Tk. 16.82, Tk. 82.54 and Tk. 13.04 respectively for the same period of the previous year.

PHARMAID 09-Nov-2021

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 14, 2021 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on September 30, 2021.

PHARMAID 02-Nov-2021

As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 09, 2021 at 3:30 PM to consider, among others, audited financial statements of the Company for the year ended on June 30, 2021.

PHARMAID 07-Oct-2021

The Company has also informed that the Board of Directors of the Company has decided to purchase 1 (one) Annealing Electrical Oven as a replacement of an old Oven for the purpose of reducing wastage and improvement of ampoule quality. Total investment value is expected to be around of BDT 20.00 lac only.

PHARMAID 26-Apr-2021

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 29, 2021 at 2:30 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended on March 31, 2021.

PHARMAID 24-Jan-2021

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 28, 2021 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended on December 31, 2020.

PHARMAID 10-Nov-2020

The Board of Directors has recommended 50% cash dividend for the year ended on June 30, 2020. Date of AGM: 24.12.2020, Time: 11:30 AM, Venue: Virtual Platform. Record date: 07.12.2020 The Company has reported EPS of Tk. 16.82, NAV per share of Tk. 82.54 and NOCFPS of Tk. 13.04 for the year ended on June 30, 2020 as against Tk. 15.48, Tk. 71.08 and Tk. 8.05 respectively for the same period of the previous year.

PHARMAID 08-Nov-2020

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 12, 2020 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on September 30, 2020.

PHARMAID 01-Nov-2020

As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 09, 2020 at 3:30 PM to consider, among others, audited financial statements of the Company for the year ended on June 30, 2020.

PHARMAID 21-Jun-2020

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on June 24, 2020 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended on March 31, 2020.

Previous Next page